A RESEARCH STUDY TO EVALUATE THE EFFECT OF ONE ADMINISTRATION OF A PEDIATRIC INHALED COMBINED FORMULATION (BECLOMETASONE PLUS FORMOTEROL) IN CHILDREN WITH ASTHMA

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-005152-10

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

-To evaluate, in children, the systemic exposure to B17MP (active metabolite of BDP) as AUC0-t, after inhalation of CHF 1535 35/4 NEXThaler® in comparison with a free combination of licensed BDP DPI and FF DPI.


Critère d'inclusion

  • Asthma

Liens